Company profilePharmaceutical#712 of 1,318 in Pakistan✓ No DRAP alerts

Merck Marker (Pvt) Ltd.

Pharmaceutical company · 13 brands · 26 molecules

Ranked #33 of 100 companies in Gastro

13 registered products 12 pharmaceutical brands 26 distinct molecules 0 DRAP alerts

Company overview

13
registered products
12
pharmaceutical brands
26
distinct molecules
12
therapeutic classes
0
DRAP alerts

Merck Marker (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 13 product registrations across 26 distinct molecules. Its portfolio is concentrated in Gastro and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Merck

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Pain Management 1

Top molecules by brand count

Fluoxetine ...... 20Mg Mg Eq. To1 brand
Fluoxetine1 brand
Levofloxacin ........................................250Mg1 brand
Inf1 brand
Levofloxacin .........................500Mg1 brand
Famotidine1 brand

Therapeutic classes

Gastro · 4Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Neuro · 2Fever/Flu/Cough · 2Anti-Infectives · 2Cardiac Care · 2Antidepressants · 1Quinolone Antibacterials · 1Antiepileptics · 1Calcium Channel Blockers · 1Pain Management · 1Drugs For Constipation · 1

Conditions treated

Ulcer/Reflux/Flatulence/Acidity · 3General Infections · 2Anxiety/Depression/Insomnia · 1Expectorant · 1Epilepsy/Convulsion · 1Cold/Dry Cough · 1Angina · 1Topical · 1Colic/Constipation · 1Hypertension · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official12 products · Rs 74.8 – Rs 807.65
DVAGO17 products · Rs 76.84 – Rs 480.5
Servaid24 products · Rs 52.8 – Rs 370
Median across source: Rs 175

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
SEARLE PAKISTAN (PVT.) LTD. holds 235 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAmitriptylineAmitryptyline
Atco Pharma International (Pvt) Ltd holds 228 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAmlodipine

Get the full profile for Merck

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.